| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.01 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | 0.074 | 0.02 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.088 | 0.02 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.099 | 0.02 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | -0.091 | 0.02 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | 0.07 | 0.02 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.02 |